跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVOTHYROXINE SODIUM INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LEVOTHYROXINE SODIUM INJECTION
Authorized
STANDARD
LEVOTHYROXINE SODIUM INJECTION
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
255fb0b1f5c33a59
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
255fb0b1f5c33a59
Drug Approval Canada Name
LEVOTHYROXINE SODIUM INJECTION
Product Name
LEVOTHYROXINE SODIUM INJECTION
Status
Marketed
Status Date
2022-06-10
Original Market Date
2022-06-10
Din
02499924
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular , Intravenous
Schedule
Prescription
Ahfs
68:36.04
Atc Original
H03AA01 LEVOTHYROXINE SODIUM
Atc Name
h 03 aa 01
Aig Number
0107794005
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
LEVOTHYROXINE SODIUM
100 MCG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
255fb0b1f5c33a59
Type
Standard
Back to Health Canada Approvals